IP Library Granted Patent US 12,263,328
Granted Patent B2
US 12,263,328 · App. 17/876,862 · Granted Apr 1, 2025

Medicament delivery device

Inventor: Oscar Alexandersson (Hanine, SE)
Assignee: SHL Medical AG
A61M5/20A61M5/2033A61M5/3157A61M5/3202A61M5/326A61M2005/2013A61M2005/2026A61M2005/206A61M2205/581A61M2205/582A61M2205/583A61M2205/584
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,263,328
App. No.
17/876,862
Granted
Apr 1, 2025
Kind
B2
Abstract

A medicament delivery device includes a generally elongated tubular housing having opposite proximal and distal parts; a needle shield sleeve slidably and coaxially arranged inside the housing with a proximal part of the sleeve protruding a distance outside the proximal part of the housing; a syringe carrier mechanism having a syringe carrier slidably and coaxially arranged within the needle shield sleeve, a syringe having a stopper, a medicament, and a needle, the syringe being coaxially arranged within the syringe carrier; and a holding member connected to the syringe carrier; a first activator member an a second activator member; a drive mechanism adapted to accumulate a drive force for moving the syringe carrier mechanism in a first step and a second step. The second activator member is arranged within an information device for producing audible, visual, and/or tactile feedback to a user about a completed injection.

Claims (40)

1. An injection device, comprising:

a tubular housing;

a syringe carrier arranged within the tubular housing, the syringe carrier configured to accept a syringe such that it is rotationally and axial fixed relative to the syringe carrier, where the syringe comprises a stopper, a medicament, and a needle;

a needle shield sleeve slidably arranged with respect to the tubular housing and the syringe carrier, where a proximal portion of the needle shield sleeve protrudes a distance outside a front end of the tubular housing to cover the needle when in a first position and when in a second position;

a plunger rod having a proximal end that engages and slides the stopper within the syringe to dispense the medicament from the needle;

a first compression spring having a proximal end that operatively engages the proximal end of the plunger rod to drive the plunger rod in a proximal direction relative to the syringe carrier;

a first activator member operatively engaged with a distal end of the needle shield sleeve such that axial distal movement of the needle shield causes axial distal movement of the first activator; and

a second activator member releasably engaged with an outside portion of the plunger rod,

wherein the first activator is tubular shaped and slidably positioned relative to and coaxially with the second activator member, and

wherein when the needle shield sleeve moves distally from the first position to a third position, the first activator causes the plunger rod to be released from the second activator.

2. The injection device of claim 1 further comprising a second compression spring having a proximal end engaged with the first activator member.

3. The injection device of claim 2 , wherein the second compression spring is pre-tensioned such that the needle shield sleeve is biased in a proximal direction.

4. The device according to claim 1 , wherein when the needle shield sleeve and the first activator member are moved distally from a start position to a first position in relation to the tubular housing, the needle shield sleeve and the first activator member move against a force of a pretensioned second compression spring operatively engaged with the first activator.

5. The device according to claim 4 , wherein the first activator moves proximally to a second position after the needle shield is removed from a delivery site, where the second position is located proximally relative to the start position of the activator.

6. The injection device of claim 1 , wherein the needle shield sleeve moves axially and proximally relative to the syringe carrier from the third position to the second position when the needle is removed from a delivery site.

7. The injection device of claim 1 further comprising an information member that is visible to the user when an injection of the medicament contained within the syringe has been completed.

8. The injection device of claim 7 , where information member is visible through a window or a passage in the housing.

9. The device according to claim 1 , wherein the information member is arranged to provide tactile information.

10. The device according to claim 1 , wherein the second activator member further comprises a tubular shape.

11. The device according to claim 1 , wherein the second activator member further comprises a plurality of longitudinally directed cut-outs arranged along a proximal outer surface of the second activator member.

12. The device according to claim 11 , wherein the plurality of longitudinally directed cut-outs form a plurality of flexible tongues.

13. The device according to claim 1 , wherein the second activator member comprises a radially extending inward directed ledge that engages a corresponding ledge on the plunger rod.

14. The device according to claim 1 , wherein the plunger rod defines an inner cavity.

15. An injection method comprising:

providing a tubular housing comprising:

a syringe carrier arranged within the tubular housing, the syringe carrier configured to accept a syringe such that it is rotationally and axial fixed relative to the syringe carrier, where the syringe comprises a stopper, a medicament, and a needle;

a needle shield sleeve slidably arranged with respect to the tubular housing and the syringe carrier, where a proximal portion of the needle shield sleeve protrudes a distance outside a front end of the tubular housing to cover the needle when in a first position and when in a second position;

a plunger rod having a proximal end that engages and slides the stopper within the syringe to dispense the medicament from the needle;

a first compression spring having a proximal end that operatively engages the proximal end of the plunger rod to drive the plunger rod in a proximal direction relative to the syringe carrier;

a first activator member comprising a release sleeve having a tubular shaped and operatively engaged with a distal end of the needle shield sleeve; and

a second activator member comprising a spring housing releasably engaged with an outside portion of the plunger rod,

pushing the proximal end of the needle shield sleeve against a delivery site to cause axial distal movement of the first activator member to overcome a pre-tensioned second compression spring operatively engaged with and biasing the first activator in a proximal direction;

sliding the first activator member relative to and coaxially with the second activator member;

moving the needle shield sleeve distally from the first position to a third position causing the plunger rod to be released from second activator; and

removing the proximal end of the needle shield sleeve from the delivery site causing the needle shield sleeve to move to the second position.

16. The method of claim 15 , further comprising providing tactile information that an injection has been completed.

17. The method of claim 15 , further comprising providing visual information that an injection has been completed.

18. The method of claim 15 , further comprising disengaging a radially extending inward directed ledge on the second activator member from a corresponding ledge on the plunger rod when the needle shield has moved to the third position.

19. The device according to claim 15 , wherein when the first activator member is moved distally from a start position to a first position in relation to the tubular housing when the needle shield is pressed against the delivery site.

20. The device according to claim 19 , wherein the first activator moves proximally to a second position after the needle shield is removed from a delivery site, where the second position is located proximally relative to the start position of the activator.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2022
From: ALEXANDERSSON, OSCAR
To: SHL GROUP AB
Reel/Frame 060670/0081 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2022
From: SHL GROUP AB
To: SHL MEDICAL AG
Reel/Frame 060670/0084 →
Priority Claims (1)
SE 0950807-8 · Oct 30, 2009 · national
Continuity (10)
Continuation 17114252 · Dec 7, 2020
Continuation 16774347 · Jan 28, 2020
Continuation 15474872 · Mar 30, 2017
Continuation 15286880 · Oct 6, 2016
Continuation 14993736 · Jan 12, 2016
Continuation 14747869 · Jun 23, 2015
Continuation 13858692 · Apr 8, 2013
Continuation 13500913
Provisional Application 61249675 · Oct 8, 2009
Related Publication 20220362470A1 · Nov 17, 2022
References Cited (57)
US 5137516A · Rand et al. · 1992 [cited by applicant]
US 5358489A · Wyrick · 1994 [cited by applicant]
US 6099503A · Stradella · 2000 [cited by applicant]
US 6221046B1 · Burroughs et al. · 2001 [cited by applicant]
US 6454743B1 · Weber · 2002 [cited by applicant]
US 6673035B1 · Rice et al. · 2004 [cited by applicant]
US 6979316B1 · Rubin et al. · 2005 [cited by applicant]
US 8180483B2 · Wada et al. · 2012 [cited by applicant]
US 8414533B2 · Alexandersson · 2013 [cited by applicant]
US 9302047B2 · Alexandersson · 2016 [cited by applicant]
US 9623182B2 · Alexandersson · 2017 [cited by applicant]
US 9649451B2 · Beek · 2017 [cited by examiner]
US 9757519B2 · Alexandersson · 2017 [cited by applicant]
US 9764089B2 · Alexandersson · 2017 [cited by applicant]
US 9867942B2 · Alexandersson · 2018 [cited by applicant]
US 20040024367A1 · Gilbert · 2004 [cited by applicant]
US 20040097883A1 · Roe · 2004 [cited by applicant]
US 20040210199A1 · Atterbury et al. · 2004 [cited by applicant]
US 20040267207A1 · Veasey et al. · 2004 [cited by applicant]
US 20050065466A1 · Vedrine · 2005 [cited by applicant]
US 20050277886A1 · Hommann et al. · 2005 [cited by applicant]
US 20070100288A1 · Bozeman et al. · 2007 [cited by applicant]
US 20070149925A1 · Edwards et al. · 2007 [cited by applicant]
US 20070191784A1 · Jacobs et al. · 2007 [cited by applicant]
US 20070265568A1 · Tsals et al. · 2007 [cited by applicant]
US 20080033393A1 · Edwards et al. · 2008 [cited by applicant]
US 20080306436A1 · Edwards et al. · 2008 [cited by applicant]
US 20090012479A1 · Moller et al. · 2009 [cited by applicant]
US 20090131875A1 · Green · 2009 [cited by applicant]
US 20090312705A1 · Grunhut et al. · 2009 [cited by applicant]
US 20100063444A1 · Wikner · 2010 [cited by applicant]
US 20100087799A1 · Galbraith et al. · 2010 [cited by applicant]
US 20100094214A1 · Abry et al. · 2010 [cited by applicant]
US 20100094253A1 · Boyd et al. · 2010 [cited by applicant]
US 20100137792A1 · Boyd et al. · 2010 [cited by applicant]
US 20100179487A1 · Woehr · 2010 [cited by applicant]
US 20110004165A1 · Iio et al. · 2011 [cited by applicant]
US 20110034878A1 · Radmer et al. · 2011 [cited by applicant]
US 20110077599A1 · Wozencroft · 2011 [cited by applicant]
US 20120010575A1 · Jones et al. · 2012 [cited by applicant]
US 20120116319A1 · Grunhut · 2012 [cited by applicant]
US 20120209192A1 · Alexandersson · 2012 [cited by applicant]
US 20130237914A1 · Alexandersson · 2013 [cited by applicant]
US 20150235571A1 · Alexandersson · 2015 [cited by applicant]
US 20150290393A1 · Alexandersson · 2015 [cited by applicant]
US 20160121048A1 · Alexandersson · 2016 [cited by applicant]
US 20160121049A1 · Alexandersson · 2016 [cited by applicant]
US 20170021102A1 · Alexandersson · 2017 [cited by applicant]
US 20170021105A1 · Alexandersson · 2017 [cited by applicant]
US 20170203042A1 · Alexandersson · 2017 [cited by applicant]
US 20210393886A1 · Nicolas · 2021 [cited by examiner]
EP 1349590A2 · 2003 [cited by applicant]
WO 0247746A1 · 2002 [cited by applicant]
WO 2004028598A1 · 2004 [cited by applicant]
WO 2007132353A2 · 2007 [cited by applicant]
Swedish Patent Office, Int'l Search Report in PCT/201 0/051004, Jan. 20, 2011. [cited by applicant]
Swedish Patent Office, Written Opinion in PCT/2010/051004, Jan. 20, 2011. [cited by applicant]